Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1866 1
1905 1
1957 1
1960 1
1962 2
1963 3
1964 1
1965 1
1966 3
1967 3
1968 3
1969 7
1970 6
1971 7
1972 13
1973 11
1974 13
1975 22
1976 24
1977 14
1978 15
1979 17
1980 14
1981 16
1982 23
1983 20
1984 9
1985 15
1986 16
1987 12
1988 12
1989 7
1990 6
1991 6
1992 10
1993 3
1994 3
1995 11
1996 4
1997 5
1998 5
1999 4
2000 5
2001 5
2002 8
2003 9
2004 9
2005 7
2006 11
2007 7
2008 7
2009 13
2010 17
2011 13
2012 21
2013 25
2014 23
2015 30
2016 28
2017 21
2018 22
2019 20
2020 25
2021 21
2022 32
2023 19
2024 9
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

744 results

Results by year

Filters applied: . Clear all
Page 1
The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial.
Schweitzer PK, Taranto-Montemurro L, Ojile JM, Thein SG, Drake CL, Rosenberg R, Corser B, Abaluck B, Sangal RB, Maynard J. Schweitzer PK, et al. Among authors: maynard j. Am J Respir Crit Care Med. 2023 Dec 15;208(12):1316-1327. doi: 10.1164/rccm.202306-1036OC. Am J Respir Crit Care Med. 2023. PMID: 37812772 Free PMC article. Clinical Trial.
Preclinical pharmacology of AZD5363, an inhibitor of AKT: pharmacodynamics, antitumor activity, and correlation of monotherapy activity with genetic background.
Davies BR, Greenwood H, Dudley P, Crafter C, Yu DH, Zhang J, Li J, Gao B, Ji Q, Maynard J, Ricketts SA, Cross D, Cosulich S, Chresta CC, Page K, Yates J, Lane C, Watson R, Luke R, Ogilvie D, Pass M. Davies BR, et al. Among authors: maynard j. Mol Cancer Ther. 2012 Apr;11(4):873-87. doi: 10.1158/1535-7163.MCT-11-0824-T. Epub 2012 Jan 31. Mol Cancer Ther. 2012. PMID: 22294718 Clinical Trial.
Antibody engineering.
Maynard J, Georgiou G. Maynard J, et al. Annu Rev Biomed Eng. 2000;2:339-76. doi: 10.1146/annurev.bioeng.2.1.339. Annu Rev Biomed Eng. 2000. PMID: 11701516 Review.
Hepatitis A.
Maynard JE. Maynard JE. Yale J Biol Med. 1976 Jul;49(3):227-33. Yale J Biol Med. 1976. PMID: 183390 Free PMC article.
Lymphangitis carcinomatosa.
Tesar PJ, Goy J, Maynard J. Tesar PJ, et al. Among authors: maynard j. Med J Aust. 1981 Jan 24;1(2):80-1. doi: 10.5694/j.1326-5377.1981.tb135328.x. Med J Aust. 1981. PMID: 7231255
Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation.
Sponholtz MR, Byrne PO, Lee AG, Ramamohan AR, Goldsmith JA, McCool RS, Zhou L, Johnson NV, Hsieh CL, Connors M, Karthigeyan KP, Crooks CM, Fuller AS, Campbell JD, Permar SR, Maynard JA, Yu D, Bottomley MJ, McLellan JS. Sponholtz MR, et al. Among authors: maynard ja. Proc Natl Acad Sci U S A. 2024 Sep 10;121(37):e2404250121. doi: 10.1073/pnas.2404250121. Epub 2024 Sep 4. Proc Natl Acad Sci U S A. 2024. PMID: 39231203 Free PMC article.
P2 purinergic receptor dysregulation in urologic disease.
Maynard JP, Sfanos KS. Maynard JP, et al. Purinergic Signal. 2022 Sep;18(3):267-287. doi: 10.1007/s11302-022-09875-1. Epub 2022 Jun 10. Purinergic Signal. 2022. PMID: 35687210 Free PMC article. Review.
744 results